BioCatalystWatch
MSLEWorkspace / MSLE / OverviewCompany library
Satellos Bioscience Inc. logo

Satellos Bioscience Inc.

Satellos Bioscience Inc. (MSLE)

Website

Price
Market cap
Next catalystExpected Q1 2027Forazapadin — TRAVERSE (CL-211) · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Forazapadin

AAK1

PreINDP1P3FilingApproved
Upcoming / outlook

Forazapadin

AAK1

PreINDP1P2P3FilingApproved
Upcoming / outlook

Forazapadin

AAK1

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Forazapadin

AAK1

PreINDP1P2P3FilingApproved
Upcoming / outlook

Forazapadin

AAK1

PreINDP1P2P3FilingApproved
Upcoming / outlook

Forazapadin

AAK1

PreINDP1P3FilingApproved
Upcoming / outlook

History / paused

PreINDP1P2P3FilingApproved
Forazapadin

AAK1

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

MSLE PR & News

PR & News

MSLE SEC archive